Immunotherapy is a powerful therapeutic approach able to re-educate the immune system to fight cancer. A key player in this process is the tumor microenvironment (TME), which is a dynamic entity characterized by a complex array of tumor and stromal cells as well as immune cell populations trafficking to the tumor site through the endothelial barrier. Recapitulating these multifaceted dynamics is critical for studying the intimate interactions between cancer and the immune system and to assess the efficacy of emerging immunotherapies, such as immune checkpoint inhibitors (ICIs) and adoptive cell-based products. Microfluidic devices offer a unique technological approach to build tumor-on-a-chip reproducing the multiple layers of complexity of cancer-immune system crosstalk. Here, we seek to review the most important biological and engineering developments of microfluidic platforms for studying cancer-immune system interactions, in both solid and hematological tumors, highlighting the role of the vascular component in immune trafficking. Emphasis is given to image processing and related algorithms for real-time monitoring and quantitative evaluation of the cellular response to microenvironmental dynamic changes. The described approaches represent a valuable tool for preclinical evaluation of immunotherapeutic strategies.

Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy / Parlato, S.; Grisanti, G.; Sinibaldi, G.; Peruzzi, G.; Casciola, C. M.; Gabriele, L.. - In: LAB ON A CHIP. - ISSN 1473-0197. - 21:2(2021), pp. 234-253. [10.1039/d0lc00799d]

Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy

Grisanti G.
Secondo
;
Sinibaldi G.;Casciola C. M.
;
2021

Abstract

Immunotherapy is a powerful therapeutic approach able to re-educate the immune system to fight cancer. A key player in this process is the tumor microenvironment (TME), which is a dynamic entity characterized by a complex array of tumor and stromal cells as well as immune cell populations trafficking to the tumor site through the endothelial barrier. Recapitulating these multifaceted dynamics is critical for studying the intimate interactions between cancer and the immune system and to assess the efficacy of emerging immunotherapies, such as immune checkpoint inhibitors (ICIs) and adoptive cell-based products. Microfluidic devices offer a unique technological approach to build tumor-on-a-chip reproducing the multiple layers of complexity of cancer-immune system crosstalk. Here, we seek to review the most important biological and engineering developments of microfluidic platforms for studying cancer-immune system interactions, in both solid and hematological tumors, highlighting the role of the vascular component in immune trafficking. Emphasis is given to image processing and related algorithms for real-time monitoring and quantitative evaluation of the cellular response to microenvironmental dynamic changes. The described approaches represent a valuable tool for preclinical evaluation of immunotherapeutic strategies.
2021
microfluidics; immunotherapy; tumor-on-a-chip
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy / Parlato, S.; Grisanti, G.; Sinibaldi, G.; Peruzzi, G.; Casciola, C. M.; Gabriele, L.. - In: LAB ON A CHIP. - ISSN 1473-0197. - 21:2(2021), pp. 234-253. [10.1039/d0lc00799d]
File allegati a questo prodotto
File Dimensione Formato  
Parlato_postprint_Tumor_2020.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 11.22 MB
Formato Adobe PDF
11.22 MB Adobe PDF   Contatta l'autore
Parlato_Tumor_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 7.01 MB
Formato Adobe PDF
7.01 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1493808
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 34
social impact